Literature DB >> 1854658

Pulmonary edema during cardiac catheterization successfully treated with bolus administration of nicardipine.

C Tamburino1, G Russo, R DiPaola, G Giuffrida.   

Abstract

This report describes a 62-year-old patient with ischemic dilated cardiomyopathy who presented pulmonary edema during cardiac catheterization. Bolus administration of nicardipine (5 mg in 5 min) into the pulmonary artery determined prompt recovery from the crisis and optimal hemodynamic conditions for completion of the catheterization. The action of the drug was mediated by the rapid reduction of the left ventricular preload and afterload. We believe that bolus administration of nicardipine is useful in treating episodes of acute left ventricular insufficiency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854658     DOI: 10.1007/bf03029775

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  4 in total

1.  Acute and chronic effects of nicardipine on rest and exercise haemodynamics in post-myocardial infarction patients with latent cardiac failure.

Authors:  M T La Rovere; A Mortara; C Opasich; G Specchia
Journal:  Eur Heart J       Date:  1989-05       Impact factor: 29.983

2.  Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure.

Authors:  B S Burlew; M Gheorghiade; S M Jafri; A D Goldberg; S Goldstein
Journal:  Am Heart J       Date:  1987-10       Impact factor: 4.749

3.  Haemodynamic effects of nicardipine hydrochloride. Studies during its use to control acute hypertension in anaesthetized patients.

Authors:  Y Kishi; F Okumura; H Furuya
Journal:  Br J Anaesth       Date:  1984-09       Impact factor: 9.166

4.  Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study.

Authors:  A Lahiri; C W Robinson; R S Kohli; M P Caruana; E B Raftery
Journal:  Clin Cardiol       Date:  1986-06       Impact factor: 2.882

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.